<DOC>
	<DOC>NCT01929785</DOC>
	<brief_summary>This is a single center observational study. Duration of the study is 1 year. Participants will be followed in 2 groups. Group 1 will include all patients who have undergone a heart transplant, through the first year post transplant. Group 2 will include heart transplant recipients from 1 year to 2 years post transplant. Groups will be enrolled simultaneously. It is anticipated each group will have 25 participants.</brief_summary>
	<brief_title>BIIR Gene to Manage Heart Allograft Patients</brief_title>
	<detailed_description>Application of the BIIR gene expression profile approach to heart transplantation clinical diagnostic issues is likely to create new means to detect rejection at the earliest stages, to help prevent progression through earlier treatment, to discover new avenues targets for treatment of heart graft rejection, and to reduce the cost of post-transplant health care</detailed_description>
	<criteria>Patients who will have or have already received a heart transplant. Patients who have no other transplant history. Men and Women ages 18 to 73 Patients who are pregnant or lactating will not be eligible for this protocol. Patients who are cognitively impaired</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>73 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>post tranplant heart allograft</keyword>
</DOC>